Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevnar 13 versus 7-valent pneumococcal conjugate vaccine in healthy infants in Taiwan
2008-004766-40Phase 3
- Sponsor
- Wyeth
- Start
- Apr 2015
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in pneumococcal disease comparing Prevnar 13 arm with 7-valent pneumococcal conjugate vaccine arm (2 arms). Primary endpoint: Serotype-specific IgG response after infant series.
02
Drugs
Prevnar 13pneumococcal 7-valent conjugate vaccine
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on 2008-004766-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004766-40.